Resource for Patients
Marijuana.Ca offers Canadians helpful and reliable information and resources about marijuana, its therapeutic potential to treat various ailments, testimonials, studies, and how Canadians can access medical marijuana through the legal medical marijuana system in Canada.
The marijuana plant has been used for thousands of years to treat various ailments in ancient China, India and Greece. More recently, there has been a torrent of interest in this complex plant that has garnered the attention of researchers, health practitioners and patients in North America.
In Canada, patients have a constitutional right to access marijuana for medical purposes. On August 24, 2016, Health Canada released the new Access to Cannabis for Medical Purposes Regulations (ACMPR). There are some significant changes/amendments made to the previous Marihuana for Medical Purposes Regulations (MMPR). We have listed some the most notable changes to the repealed MMPR at the following link: Synopsis of the ACMPR.
Home Growing and Designated Growing
Under the ACMPR, Canadians who have been authorized by their health care practitioner to access cannabis for medical purposes will be able to produce a limited amount of cannabis for their own medical purposes, or designate someone to produce it for them. They will also continue to have the option of purchasing safe, quality-controlled cannabis from one of the many producers licensed by Health Canada.
Individuals wishing to produce a limited amount of cannabis for their own medical purposes, or to designate someone to produce it for them, will need to obtain authorization from their health care practitioner and register with Health Canada.
Click on the following link(s) to find:
For more details pertaining to the new regulations, please review the following links:
New ACMPR /Medical Marijuana regulations are now available @ the Canada Gazette.
A Brief History Of Medical Marijuana Regulations in Canada
Under the 2001 Medical Marijuana Access Regulations (MMAR) system, patients required an Authorization to Possess (ATP) license, and with this, could source their medical marijuana from Health Canada, grow their own, or designate a grower. The 2013 Marijuana for Medical Purposes Regulations (MMPR) ushered in a new program - where licensed producers were the only legal source of marijuana in Canada. Under this program, personal and designated growing was no longer legal.
During the transition from the MMAR to the MMPR program, Health Canada ordered patients and designated growers to destroy their crops and stored marijuana before they transitioned to licensed producers, now their only source of legal medical marijuana.
In response to Health Canada's demand, Niel Allard and plaintiffs, launched a case against the government. They argued that being forced into the MMPR program would deny them affordable access to necessary medicine. An injunction was granted to allow growers under the MMAR program to continue producing medical marijuana - until a decision was reached
The Allard court case that addressed some of the challenges pertaining to patient access to medical marijuana was, for all intents and purposes, a victory for patients, as the federal court judge recognized the limitations of the MMPR regulatory system. On February 24, 2016, the government did not appeal the Federal Court Decision that found the MMPR to be unconstitutional. On August 11, 2016, in response to the Federal Court of Canada's decision in Allard v. Canada, Health Canada announced the Access to Cannabis for Medical Purposes Regulations (ACMPR). The ACMPR has replaced the 2013 MMPR and 2001 MMAR, as the regulations governing Canada's current medical marijuana program.
Consumer information for Canadians who are considering marijuana as a medicine:
Information - Cannabis (Marihuana, Marijuana)
Source: Health Canada: http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/cons-eng.php
The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes.
About This Product
What the product may be used for
Your health care practitioner may have authorized the use of cannabis (marihuana, marijuana) for the relief of one or more of the following symptoms associated with a variety of disorders which have not responded to conventional medical treatments. These symptoms (or conditions) may include: severe refractory nausea and vomiting associated with cancer chemotherapy; loss of appetite and body weight in cancer patients and patients with HIV/AIDS; pain and muscle spasms associated with multiple sclerosis; chronic non-cancer pain (mainly neuropathic); severe refractory cancer-associated pain; insomnia and depressed mood associated with chronic diseases (HIV/AIDS, chronic non-cancer pain); and symptoms encountered in the palliative/end-of-life care setting. This is not an exhaustive list of symptoms or conditions for which cannabis may be authorized for use by your health care practitioner.
The potential therapeutic and adverse effects associated with cannabis use may vary depending on the amount of cannabis used and the concentration of cannabinoids in the cannabis product, the frequency of cannabis use, the patient's age and medical condition, previous experience with cannabis or cannabinoids, and the use of other prescription or non-prescription drugs. For more detailed information on potential therapeutic uses and adverse effects, please consult the "Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the Cannabinoids".
What the active ingredients might be
The type and amount of these ingredients may vary depending on the cannabis strain.
What the product does
The principal active ingredient in cannabis (THC) acts on very specific targets found in the body known as cannabinoid receptors. Cannabinoids may also have targets other than the cannabinoid receptors. Cannabinoid receptors are found throughout the body, in most tissues and organs, but they are especially numerous in the brain and nervous system. Cannabinoid receptors are involved in the regulation of many bodily functions including: brain and nervous system activity, heart rate and blood pressure, digestion, inflammation, immune system activity, perception of pain, reproduction, wake/sleep cycle, regulation of stress and emotional state and many other functions. For more detailed information, please consult the "Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the Cannabinoids".
How the product is supplied
Dried marijuana plant material, fresh marijuana plant material and products derived from fresh or dried marijuana.
How to store the product
Dried marijuana plant material and cannabis products should be stored in a cool place,preferably away from light and air. See manufacturer’s instructions on the product label for recommended storage conditions.
Keep any cannabis and cannabis products out of the reach of children and locked in a safe place to prevent theft, misuse and accidental ingestion by children. This product should not be shared with anyone else.
Procedures for Accessing Cannabis for Medical Purposes from a Licensed Producer
To register with a licensed producer under the ACMPR, you need to follow the following steps:
Vaporizers are becoming an increasingly popular method to administer marijuana. A vaporizer is a device that uses a heating process that reaches past the boiling point to release the active ingredients, but not high enough to burn the plant material. The collected vapour is then inhaled.
Vaporizers often have various temperature settings, which can impact the amount of cannabinoids in the vapour.
A good vaporizer at the right heat setting can release up to 95% of all available cannabinoids. Cannabinoids (e.g. THC and CBD) are chemical compounds found in the marijuana plant, which when ingested, bind to the body’s cannabinoid receptors. This process is known to have medicinal value and applications for various aliments. (Please visit the review article The Therapeutic Potential of Cannabis and Cannabinoids for more information on this topic.)
There are clinical trials and studies that suggest vaporizing may be a healthier, efficient and more practical alternative to smoked marijuana, because this method of ingestion offers fast acting effects similar to smoking, provides better dosage control and potentially reduces health risks.
Medical marijuana patients can choose to consume marijuana via infusing food and drinks with dried marijuana or extracts. Please note that ingestion of marijuana edibles have a delayed onset effect, which can take up to 2 hours or longer.
» On June 11, 2015, the Supreme Court of Canada ruled to legalize marijuana oils and edibles.
This landmark decision makes medical marijuana legal in all forms, including marijuana-infused cookies, brownies, muffins, oils, teas and juices.
3. Marijuana Oil Extracts
Ingestible marijuana oil extracts come in various concentrations and delivery methods and are taken orally. The delivery systems available to ingest oils in Canada (through licensed producers) are usually in capsules or bottles. The bottles come with a dosing syringe to measure dosage. The oils can be orally ingested or infused with food and drink to make edibles.
Please note that ingestion of marijuana edibles have a delayed onset effect, which can take up to 2 hours or longer.
Links to Resources
Marijuana.Ca has provided the following links to resources as references for visitors to the site and does not endorse the content contained within the links that are provided.
Patient Support & Advocacy Groups
Cannabinoid Research Organizations
Community-Based Healthcare Organizations
Non-Governmental / Non-Profit Organizations
Links to Scientific Research and Clinical Studies on Medical Marijuana
Cannabis-Med.Org - Clinical Studies and Case Reports
On this site you will find clinical studies with cannabis or single cannabinoids in different diseases and case reports on the use of cannabis by patients.
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.
Please visit Cannabis-Med.org
Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the cannabis plant.
Please visit ProjectCBD.Org
Centre for Medical Cannabis Research (CMCR)
University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.
Please visit CMCR.ucsd.edu
1023 Articles with the search criteria of (Cannabis OR Marijuana) AND (Pain)
Please visit PubMed.gov
89 Articles with the search criteria of (Palliative OR Hospice) AND (Cannabis OR Marijuana)
Please visit PubMed.gov
US National Library of Medicine: Journal Citation Database
The Therapeutic Potential of Cannabis and Cannabinoids: Selective Literature review
Please visit PubMed Central
* The material on this website is provided for educational and informational purposes only, and is not intended to be a substitute for a health care provider's consultation. Please consult your own appropriate health care provider about the applicability of any opinions or recommendations with respect to your own symptoms or medical conditions. The information herein does not constitute health, legal or technical advice.
The Medicine Fund